About Genepharm
Genepharm is a Healthcare company based in Pallini (Greece) founded in 1967, and was acquired by MSPharma in April 2019. Generic drugs are manufactured in Pallini, Greece. It operates on a Reseller / Distribution model. Genepharm offers products and services including Conventional Solids and Oncological Solids. Its focus areas include Pharmaceuticals and Generic Drugs. Its legal entity in India is GENEPHARM S.A (U24239WB2006PTC110197).
Company details
Genepharm is involved in the development and manufacturing of pharmaceutical products, focusing on conventional and oncological solids. Operations are conducted in a state-of-the-art facility in Pallini, Greece, adhering to European specifications. The company serves both domestic and international markets, with a presence in over 90 countries through strategic alliances with leading pharmaceutical firms. Therapeutic areas covered include cardiology, oncology, neurology, and more. Continuous investment in infrastructure and technology is prioritized to enhance product development and global reach.
- Headquarters Pallini, Greece
- Stage Acquired
- SectorsHealthcare
- Phone•••• ••••
- Website genepharm.com/index.php/en
- Social LinkedIn Facebook YouTube
- Acquired by MSPharma (Apr 2019)
- Legal Name Genepharm S.A.
- Date of Incorporation 29 Jun, 2006
- Jurisdiction Kolkata, West Bengal, India
Associated legal entities of Genepharm
Genepharm operates through Genepharm India Private Limited (strike off). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Genepharm India Private Limited CIN U24239WB2006PTC110197 | Strike Off | 29 Jun 2006 | Kolkata, West Bengal | 2 | View details |
Products & Services of Genepharm
Genepharm offers a comprehensive portfolio of products and services, including Conventional Solids and Oncological Solids.
Conventional tablets and capsules are produced for various therapies.
Oncological tablets and capsules are manufactured for cancer treatment.
Apps and channels of Genepharm
its YouTube channel Genepharm S.A. has 29 subscribers.
Funding Insights of Genepharm
- Total Rounds 1
- Last Round Grant — $2.18M
- First Round $2.18M
(Sep 2007)
- Investors Count 1
All 1 funding rounds of Genepharm with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2007 | $2.18M | Grant | – | – |
2 investors in total: 2 institutional.
Investors in Genepharm
Genepharm has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and MSPharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Generic formulations are manufactured by MSPharma across multiple therapeutic categories. | 1989 | mspharma.com | Amman, Jordan |
Investor details for Genepharm
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Genepharm India Private Limited (Genepharm)
Genepharm India Private Limited is the primary company behind Genepharm. The board of Genepharm India Private Limited currently have 2 directors; the longest-serving is Neena Sanjay Katrekar, appointed in 2009. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Neena Sanjay Katrekar DIN 02588951 | Director | 30 Mar 2009 | 17 yrs 6 mo | Genepharm India Private Limited |
| Venkat Kamalakar Bundla DIN 01968306 | Additional Director | 07 Jun 2012 | 14 yrs 4 mo | Genepharm India Private Limited |
Timeline of Genepharm
3 dated milestones of Genepharm across 52 years, from founding to its latest funding, stage changes and deals.
- Founded Genepharm is founded.
- Funding First funding round of $2.2M.
- Exit Acquired by MSPharma.
Web traffic of Genepharm
The website of Genepharm (genepharm.com) receives about 1.7K visits a month.
- Monthly visits1.7K
▲ 34.1% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Genepharm
Genepharm was founded in 1967 and raised its 1st funding round 40 years after it was founded.
Genepharm is headquartered in Pallini, Greece. It is registered at Pallini, Attica, Greece.
Genepharm is involved in the development and manufacturing of pharmaceutical products, focusing on conventional and oncological solids. Operations are conducted in a state-of-the-art facility in Pallini, Greece, adhering to European specifications. The company serves both domestic and international markets, with a presence in over 90 countries through strategic alliances with leading pharmaceutical firms. Therapeutic areas covered include cardiology, oncology, neurology, and more. Continuous investment in infrastructure and technology is prioritized to enhance product development and global reach.
Genepharm offers Conventional Solids and Oncological Solids.
Genepharm operates through Genepharm India Private Limited.
Yes. Genepharm was acquired by MSPharma in April 2019.
The legal entities of Genepharm currently have 2 directors, including Neena Sanjay Katrekar, Venkat Kamalakar Bundla.